MedPath

Study of Colorectal Procedures With the Levita Magnetic Surgical System

Not Applicable
Completed
Conditions
Colorectal Procedures
Interventions
Device: Levita Magnetic Surgical System
Registration Number
NCT03960684
Lead Sponsor
Levita Magnetics
Brief Summary

The purpose of this study is to evaluate the safety and effectiveness of the Levita Magnetic Surgical System in patients undergoing colorectal procedures.

Detailed Description

Prospective, multicenter, single-arm, open label study designed to assess the safety and effectiveness of the Levita Magnetic Surgical System in colorectal procedures.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
31
Inclusion Criteria
  • Subject is at least 18 years of age
  • Subject is scheduled to undergo elective colorectal surgery
Exclusion Criteria
  • Significant comorbidities
  • Subjects with pacemakers, defibrillators, or other electromedical implants
  • Subjects with ferromagnetic implants
  • Clinical history of impaired coagulation
  • Subject has an anatomical abnormality noted after initiation of index procedure that would prevent device use
  • Subject is not likely to comply with the follow-up evaluation schedule
  • Subject is participating in another clinical trial

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Levita Magnetic Surgical SystemLevita Magnetic Surgical SystemLevita Magnetic Surgical System
Primary Outcome Measures
NameTimeMethod
Number and Types of Tools Required to Retract the Colon or Peri-colorectal TissuesDuring planned colorectal procedure

Ability to adequately retract the colon, peri-colorectal tissues or adjacent organs to achieve an effective exposure of the target tissue. Adequate retraction is achieved if it is not necessary to replace the Levita Magnetic Surgical System with another instrument to retract these tissues during the procedure.

Cumulative number of additional tools required across all participants.

Device Related Adverse EventsThrough 30 days post colorectal procedure/study completion.

All adverse events will be recorded and allocated as to relatedness to device, procedure or other.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hospital del Salvador

🇨🇱

Santiago, Chile

© Copyright 2025. All Rights Reserved by MedPath